Dashboard
Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.93 times
- Poor long term growth as Net Sales has grown by an annual rate of 12.99% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.93 times
- The company has been able to generate a Return on Equity (avg) of 5.01% signifying low profitability per unit of shareholders funds
Healthy long term growth as Operating profit has grown by an annual rate 45.98%
Flat results in Sep 26
Stock is technically in a Mildly Bullish range
With ROCE of 9, it has a Attractive valuation with a 2.8 Enterprise value to Capital Employed
Stock DNA
Healthcare Services
INR 122 Cr (Micro Cap)
68.00
63
0.00%
1.20
7.16%
5.01
Total Returns (Price + Dividend) 
Choksi Laborator for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Choksi Laboratories Ltd is Rated Hold by MarketsMOJO
Choksi Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Choksi Laboratories Ltd is Rated Hold by MarketsMOJO
Choksi Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Choksi Laboratories Ltd is Rated Hold
Choksi Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 October 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSESubmission of newspaper publication of the financial result for the period ended 30.09.2026
Board Meeting Outcome for Meeting Of Board Of Directors Held On 14.11.2026
14-Nov-2026 | Source : BSE1. Considered and approved the Unaudited Financial Results for the Quarter and Half Year ended on 30th September 2026 along with the Limited review report;
Submission Of Financial Result For The Quarter And Half Year Ended 30.09.2026
14-Nov-2026 | Source : BSEConsidered and approved the Unaudited Financial Results for the quarter and half year ended on 30th September2026 along with the Limited Review Report
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 2 FIIs (10.01%)
Sunil Kumar Choksi (7.51%)
Nexus Global Opportunities Fund (9.48%)
47.96%
Quarterly Results Snapshot (Standalone) - Sep'26 - YoY
YoY Growth in quarter ended Sep 2026 is 11.78% vs 20.09% in Sep 2025
YoY Growth in quarter ended Sep 2026 is -29.17% vs 200.00% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 11.80% vs 19.19% in Sep 2024
Growth in half year ended Sep 2025 is 26.00% vs 38.89% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 9.22% vs 18.81% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 54.10% vs 45.24% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 10.12% vs 13.84% in Mar 2025
YoY Growth in year ended Mar 2026 is 28.95% vs 36.94% in Mar 2025